2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$118.81+$3.78 (+3.29%)
Price as of Jun 23, 2026 5:08 PM EDT- $7.4BMarket Cap
- 115.57%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$118.81+$3.78 (+3.29%)
Earnings Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 3.90% | ||
12-Month Momentum | 89.13% | ||
3-Month Risk Adjusted Momentum | 20.76% | ||
12-Month Risk Adjusted Momentum | 182.41% |
True Yield
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.52% | ||
Net Debt Paydown Yield | 0.002% |
Financial Health Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |